Yatharth Hospital & Trauma Care Services Limited has informed the Exchange about Transcript of Investors conference call organized on May 27, 2025.
YATHARTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Yatharth Hospital reported FY25 revenue of INR8,805 million, up 31% year-on-year, with EBITDA of INR2,202 million (up 22%) and net profit of INR1,306 million (up 14%). Q4 revenue grew 30% to INR2,318 million, though EBITDA margin dipped to 24.6% from 26.2% due to operational losses at the newly started Greater Faridabad unit. The company holds a net cash position of INR5,032 million, with FY25 operating cash flow of INR1,496 million. Management announced two new hospitals — a 300-bed facility in New Delhi and a 400-bed hospital in Faridabad — both expected to start operations within a month. Capex of around INR300 crores is planned for FY26 and FY27 for existing hospitals, plus brownfield expansion of 200 beds at Noida Extension and 250 beds at Greater Noida. The promoter pledge of about 8% of holdings was clarified as relating to a personal family settlement following the passing of an extended family member, expected to be released within a year. Management guided that Q4 margins should hold as a baseline for FY26 and FY27, with recovery expected as new hospitals ramp up over 12–15 months.
The strong revenue growth and clear expansion roadmap are positives for the stock, but near-term margins will stay under pressure as two new hospitals go live. Investors should watch for ramp-up of the new Delhi and Faridabad facilities and any update on the tax matter at the parent entity, as these will be the key swing factors for FY26 earnings.